GGPI & Polestar on Track to Close with Low Redemptions

by | Jun 21, 2022

Hotly anticipated SPAC expected to trade as PSNY 6/24

** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

Gores Guggenheim (GGPI) and Polestar is one of the only current pre-close SPAC deals that appears to be positively anticipated by the market (here’s looking at you DWAC). The long awaited merger, announced in September of 2021, is now finally expected to close this week following its merger vote on Wednesday 6/22. To boot, the company said it expects to have a maximum of 25% redemptions as part of its closing process, which would come in far below the recent average redemption rates.

Source: Boardroom Alpha

Polestar, an EV company that actually has shipped cars, will trade as PSNY this Thursday, 6/24. ICYMI here is some of our recent coverage on Polestar including our conversation with CEO Thomas Ingenlath. GGPI stock, while down from its highs, has been one of the lone SPAC stocks to trade at a premium to NAV. Shares have dipped below NAV since it went ex-redemption.

Goldenstone Acquisition Rumored to Merge With Roxe

According to a Reuters report, Goldenstone Acquisition (GDST) is rumored to be nearing a $3.6B deal with blockchain-based payments company Roxe Holdings. The deal could be announced as early as Tuesday afternoon. GDST is a $57.5M SPAC that just priced in March-2022 and would mark one of the quickest deal pacts in recent SPAC memory. Particularly surprising given the very negative current market sentiment surrounding both SPACs and the general crypto/blockchain landscape.

SpringBig Clarifies Public Float

Recent De-SPAC SpringBig (SBIG) which saw > 90% redemptions at its merger vote has confirmed that it currently has a 6.6M public share float and $15M on its balance sheet since debuting as a public company following its deSPAC transaction.

Elsewhere in SPACs

SPACs continue to abandon their plans to go public, the latest being Lamar Partnering and Lionheart IV, from Lionheart Capital. Lionheart is the team behind the disaster that is MSP Recovery. Bloomberg with a nice recent take on the MSP Recovery story, its going concern and precipitous drop in share value.

SPAC Calendar

Biggest Daily Movers

Biggest Gainers

9.79% ~ $ 10.88 | KNSW – KnightSwan Acquisiton Corp (Pre-Deal)
2.11% ~ $ 28.58 | DWAC – Digital World Acquisition Corp. (Announced)
1.70% ~ $ 10.19 | GGAA – Genesis Growth Tech Acquisition Corp. (Pre-Deal)
1.40% ~ $ 10.11 | LAAA – Lakeshore Acquisition I Corp. (Announced)
1.12% ~ $ 9.94 | TZPS – TZP Strategies Acquisition Corp. (Pre-Deal)
1.02% ~ $ 9.95 | NVAC – NorthView Acquisition Corp (Pre-Deal)
.90% ~ $ 10.05 | HCMA – HCM Acquisition Corp (Pre-Deal)
.82% ~ $ 9.89 | MEAC – Mercury Ecommerce Acquisition Corp (Pre-Deal)
.81% ~ $ 9.94 | GDST – Goldenstone Acquisition Ltd. (Pre-Deal)
.80% ~ $ 9.94 | GIAC – Gesher I Acquisition Corp. (Announced)
.80% ~ $ 10.09 | GIA – GigCapital5, Inc. (Pre-Deal)
.79% ~ $ 10.15 | TOAC – Talon 1 Acquisition Corp (Pre-Deal)
.72% ~ $ 9.86 | KRNL – Kernel Group Holdings, Inc. (Pre-Deal)
.71% ~ $ 9.98 | FIAC – Focus Impact Acquisition Corp. (Pre-Deal)
.70% ~ $ 10.05 | MNTN – Everest Consolidator Acquisition Corp (Pre-Deal)
.61% ~ $ 9.82 | RACB – Research Alliance Corp. II (Pre-Deal)
.61% ~ $ 9.89 | OHAA – Opy Acquisition Corp. I (Pre-Deal)
.60% ~ $ 9.99 | GDNR – Gardiner Healthcare Acquisitions Corp. (Pre-Deal)
.60% ~ $ 10.00 | BYNO – byNordic Acquisition Corporation (Pre-Deal)
.51% ~ $ 9.81 | ARRW – Arrowroot Acquisition Corp. (Pre-Deal)

Biggest Losers

-12.42% ~ $ 9.80 | NHIC – NewHold Investment Corp. II (Pre-Deal)
-8.34% ~ $ 9.89 | CIIG – CIIG Capital Partners II, Inc. (Pre-Deal)
-6.22% ~ $ 9.95 | HAIA – Healthcare AI Acquisition Corp. (Pre-Deal)
-5.88% ~ $ 9.60 | NLIT – Northern Lights Acquisition Corp. (Announced)
-4.67% ~ $ 10.01 | TRON – Corner Growth Acquisition Corp. 2 (Pre-Deal)
-3.96% ~ $ 9.69 | GGPI – Gores Guggenheim, Inc (Announced)
-1.32% ~ $ 9.74 | BLEU – bleuacacia ltd (Pre-Deal)
-1.28% ~ $ 10.02 | USCT – TKB Critical Technologies 1 (Pre-Deal)
-1.21% ~ $ 9.78 | DISA – Disruptive Acquisition Corp I (Pre-Deal)
-1.10% ~ $ 9.88 | ZING – FTAC Zeus Acquisition Corp. (Pre-Deal)
-1.07% ~ $ 5.57 | EJFA – EJF Acquisition Corp (Announced)
-1.01% ~ $ 9.79 | BYTS – BYTE Acquisition Corp. (Pre-Deal)
-.96% ~ $ 9.78 | GTPB – GORES TECHNOLOGY PARTNERS II, INC. (Pre-Deal)
-.81% ~ $ 9.85 | SHQA – Shelter Acquisition Corporation I (Pre-Deal)
-.80% ~ $ 9.97 | DUNE – Dune Acquisition Corporation (Announced)
-.71% ~ $ 9.85 | ROCL – Roth CH Acquisition V Co. (Pre-Deal)
-.70% ~ $ 9.90 | DSAC – Duddell Street Acquisition Corp (Announced)
-.68% ~ $ 10.20 | KINZ – KINS Technology Group Inc. (Pre-Deal)
-.62% ~ $ 9.63 | IPAX – Inflection Point Acquisition Corp. (Pre-Deal)
-.61% ~ $ 9.72 | TCVA – TCV Acquisition Corp. (Pre-Deal)

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – July 2022

Liquidations, cancelled deals, and a dead IPO market highlight Boardroom Alpha’s July 2022 SPAC market review. Read for a full recap.

SPAC Market Review – June 2022

Boardroom Alpha’s June 2022 SPAC market review looks at the latest trends in SPACs, where the market is heading a recap of activity.

SPAC Market Review – May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

SPAC Research & Analysis

Boardroom Alpha Digest: Mon, Jan 9

Rite Aide Corporation (RAD) parts ways with Heyward Donigan and Paya Holdings (PAYA) acquisition highlight Monday’s daily digest.

Boardroom Alpha Digest: Thurs, Jan 5

Boardroom Alpha’s Daily Digest highlights include Elizabeth Spaulding resigning as CEO of Stitch Fix (SFIX) and JNJ’s Kenvue filing for an IPO

SPAC Market Review – December 2022

December’s SPAC market review takes a look by the numbers of the month’s SPAC activity and how the market currently stands going into 2023.

SPACs Today: Wednesday, Dec 14

Rice Acquisition Corp. II (RONI) with an encouraging energy transaction, and the rest of the day’s SPAC news.

SPACs Today: Monday, Dec 12

Venus Acquisition Corporation (VENA) finally closed and changes ticker to MLGO, and the rest of the day’s SPAC news.

SPAC Market Review – November 2022

November’s SPAC market review paints a picture of a SPAC market rushing towards the exit with high, and accelerating liquidations, more deal terminations, and almost no new SPAC IPOs.

Know Who Drives Return Podcast

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. WindAcre increases its stake and opposes NSLN takeover bid. Activist Jana Partners brings lessons learned at ConAgra (CAG) to Treehouse Foods (THS). And other notable special situations.

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. Management shakeup at Faraday Future (FIFE) is an all-too familiar story in the world of EV SPACs. Blackrock to be 75% net-zero aligned by 2030, and Jana closing in (again) at Treehouse Foods (THS).

FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry

Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.